Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, BOSTON SCIENTIFIC CORP reported revenue of $20.07B, up 19.9% year over year. Operating margin was 18.0% and net margin 14.4%, on a free-cash-flow margin of 18.2% with capital expenditure at 4.4% of revenue. Every figure is computed directly from BSX's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $20.07B | 18.0% | 14.4% |
| FY2024 | $16.75B | 15.5% | 11.0% |
| FY2023 | $14.24B | 16.5% | 11.2% |
| FY2022 | $12.68B | 13.0% | 5.5% |
| FY2021 | $11.89B | 10.1% | 8.8% |
How does BSX compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.